A proteomics test measures many proteins in a blood sample at once, rather than one at a time, to read the pattern the body is producing. For immune signaling, ultra-sensitive multiplex proteomics can quantify cytokines that circulate at vanishingly low concentrations, often at the femtogram-per-milliliter level, which routine assays miss. Muno Mirror uses this approach to benchmark each marker against a healthy reference and track it over time.
Key takeaways
- A proteomics test reads many proteins at once, so it captures the immune system as a pattern instead of a single number.
- Ultra-sensitive multiplex assays can quantify cytokines like IL-6, TNF, and IFN-gamma at femtogram-per-milliliter concentrations, a range where standard clinical assays often report nothing.
- Absolute concentrations, actual amounts rather than relative signals, are what make results comparable from one test to the next.
- A healthy benchmark turns each value into something meaningful, so "in range" becomes "optimal or not."
- Because the method is consistent, retesting turns a single snapshot into a trend, for research and monitoring, not diagnosis.
What is proteomics testing?
Proteins are the molecules that do the work in the body, and the proteome is the full set of them present at a given moment. Where genetics describes what could happen, proteins reflect what is happening right now. A proteomics test measures a large number of these proteins from one sample, at the same time. For immune health, the proteins of interest are cytokines, chemokines, interferons, and their receptors, the signaling molecules immune cells use to coordinate. Measuring them one by one gives a series of disconnected results. Measuring hundreds together, on a single sample, keeps them comparable and lets the pattern emerge. Modern affinity-based proteomics platforms use antibody or aptamer probes to quantify thousands of proteins from a single sample at once. That shift from a single value to a resolved profile is the core idea of a proteomics blood test, and it is why proteomics has become central to modern immune research.
Why can ultra-sensitive assays measure cytokines that routine tests miss?
Many of the most informative immune signals are present in blood at extraordinarily low concentrations. Cytokines such as IL-6, TNF, and IFN-gamma can circulate in the femtogram-per-milliliter to picogram-per-milliliter range, far below the reliable detection limit of many standard clinical assays. When a routine test reports a cytokine as undetectable, that often means the assay could not reach low enough, not that the protein is truly absent. Ultra-sensitive multiplex proteomics is built to close that gap, using amplified detection chemistry so that faint signals become quantifiable. Single-molecule cytokine immunoassays have reported detection limits down to the low femtogram-per-milliliter range, roughly a thousandfold more sensitive than conventional assays. The practical consequence is meaningful. A pathway that looks silent on a conventional test can be clearly readable on a sensitive one, which is exactly the situation many people with chronic, contested illness find themselves in when standard labs come back empty. For a closer look at reading these signals together, see our guide to cytokine panel testing.
Why do absolute concentrations matter?
Not all protein measurements are equal. Some methods return a relative signal, useful for comparing samples within a single run but hard to line up across different runs or different days. Absolute concentrations, an actual amount such as a value in picograms per milliliter, are anchored to a real scale. That anchoring is what makes longitudinal tracking possible. If your first test reports a marker as a concrete concentration and a later test uses the same calibrated method, the two numbers can be compared directly, and a change is a real change rather than an artifact of how the run was normalized. For anyone whose goal is to watch what shifts over time, absolute quantification is not a technical footnote. It is the foundation that lets one result be meaningfully compared to the next.
Why does a healthy benchmark matter?
A number on its own does not tell you much. A cytokine concentration is only interpretable next to a reference, and the most useful reference is a healthy benchmark: where the same marker sits in people who are well. This is what turns raw measurement into information. Instead of a value floating without context, you see whether a marker is within a healthy range or outside it, and by how much. It also reframes the familiar frustration of normal labs. Standard results are often reported against broad reference intervals designed to flag overt disease, so a value can be technically normal and still sit well away from where a healthy immune system tends to run. Benchmarking each marker against a healthy reference is what makes "in range" become the more useful question of "optimal or not." For how this connects to long-term illness, see our overview of chronic inflammation and chronic illness.
How does proteomics testing help track change over time?
Put the pieces together and the value becomes clear. Breadth captures the immune system as a pattern. Sensitivity reaches the low-abundance signals that matter. Absolute concentrations keep results comparable. A healthy benchmark makes each value interpretable. Consistency across tests turns a single snapshot into a trend. That is what Muno Mirror is built to do: measure a broad inflammation proteomics panel from a small at-home microsample, benchmark each marker against a healthy reference, and let you retest to see what actually moved. It is a measurement and monitoring tool for research and informational use. It does not diagnose, detect, or screen for any disease, and it is not a substitute for care from your own clinician. It is meant to give you and your doctor objective, benchmarked data to discuss. If you want to see the full set of markers, Muno Mirror measures a 250-plex inflammation panel and lets you track change over time.
Frequently asked questions
What does a proteomics test measure?
It measures many proteins from a single sample at once. For immune health, that means cytokines, chemokines, interferons, and their receptors, the signaling molecules immune cells use. Reading them together gives a resolved profile rather than a single isolated value.
Why can proteomics detect cytokines that a regular blood test cannot?
Cytokines like IL-6, TNF, and IFN-gamma often circulate at femtogram-per-milliliter to picogram-per-milliliter levels, below the detection limit of many routine assays. Ultra-sensitive multiplex proteomics uses amplified detection so these faint signals become quantifiable, so a pathway that looks silent on a standard test can be readable.
What is the difference between absolute and relative measurements?
A relative measurement is a signal useful for comparing samples within one run but hard to align across runs. An absolute concentration is an actual amount on a real scale, such as picograms per milliliter. Absolute values can be compared directly across tests and days, which is what makes tracking over time reliable.
Does a proteomics test diagnose disease?
No. A proteomics test measures and benchmarks proteins for research and informational use. It does not diagnose, detect, or screen for any disease, and it is not a substitute for a doctor. The results are objective data to review with your own clinician alongside your symptoms and history.